In one single-center trial of 72 subjects using a controlled-adverse-environment model, the T4 eye drop did not meet its co-primary endpoints (ocular discomfort and inferior corneal staining) at the primary time point, but it did produce statistically significant improvements on several secondary endpoints, including central and superior corneal staining, with no adverse events reported
Most available data comes from in vitro experiments and animal models, forming an early foundation for ongoing investigation
Thats a conversation with your doctor, not a coin flip
The number of participants in the Se-only arm varied from 16 to 105 subjects
it can maintain up to 20 times longer-lasting effects (similar to the difference between an IV drip and a single injection)
In another trial, full-body resistance training for 10 weeks also led to increased NAD + , NADH levels, and SIRT activity in muscle 329